Satoshi Nakao

3.0k total citations
127 papers, 2.4k citations indexed

About

Satoshi Nakao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering. According to data from OpenAlex, Satoshi Nakao has authored 127 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Electrical and Electronic Engineering. Recurrent topics in Satoshi Nakao's work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Drug-Induced Adverse Reactions (9 papers) and Pharmacy and Medical Practices (9 papers). Satoshi Nakao is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (13 papers), Drug-Induced Adverse Reactions (9 papers) and Pharmacy and Medical Practices (9 papers). Satoshi Nakao collaborates with scholars based in Japan, United States and Netherlands. Satoshi Nakao's co-authors include J.G. Wijmans, C.A. Smolders, Takeo Yamaguchi, Liang‐Yin Chu, J.W.A. van den Berg, Taro Hitosugi, Fusae Miyata, Naoomi Yamada, Takuya Hasegawa and Yasushi Hirose and has published in prestigious journals such as Advanced Materials, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Satoshi Nakao

115 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Nakao Japan 26 618 588 517 510 210 127 2.4k
Mei‐Rong Huang China 33 586 0.9× 1.2k 2.1× 318 0.6× 771 1.5× 246 1.2× 84 3.6k
Xianliang Li China 30 459 0.7× 595 1.0× 155 0.3× 590 1.2× 132 0.6× 149 2.5k
Shoji Nagaoka Japan 35 1.1k 1.8× 497 0.8× 293 0.6× 997 2.0× 107 0.5× 193 3.7k
Xiaoli Liu China 33 1.1k 1.8× 313 0.5× 178 0.3× 703 1.4× 98 0.5× 211 4.0k
Peng Li China 26 418 0.7× 324 0.6× 189 0.4× 1.0k 2.0× 75 0.4× 140 2.4k
Guisheng Qi China 26 410 0.7× 301 0.5× 341 0.7× 519 1.0× 44 0.2× 92 2.0k
Lili Jiang China 26 322 0.5× 660 1.1× 149 0.3× 620 1.2× 114 0.5× 140 2.5k
Jihui Li China 23 226 0.4× 292 0.5× 156 0.3× 405 0.8× 142 0.7× 142 1.8k
Xiaoqing Wang China 30 454 0.7× 378 0.6× 170 0.3× 833 1.6× 236 1.1× 219 3.4k
D. Lerche Germany 25 478 0.8× 190 0.3× 204 0.4× 321 0.6× 297 1.4× 124 2.1k

Countries citing papers authored by Satoshi Nakao

Since Specialization
Citations

This map shows the geographic impact of Satoshi Nakao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Nakao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Nakao more than expected).

Fields of papers citing papers by Satoshi Nakao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Nakao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Nakao. The network helps show where Satoshi Nakao may publish in the future.

Co-authorship network of co-authors of Satoshi Nakao

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Nakao. A scholar is included among the top collaborators of Satoshi Nakao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Nakao. Satoshi Nakao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakao, Satoshi, et al.. (2024). Analysis of Adverse Events With Janus Kinase Inhibitors Reported to Spontaneous Reporting System. Pharmaceutical and Biomedical Research. 10(3). 203–228.
2.
Nakao, Satoshi, et al.. (2024). Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. 16(8). e68260–e68260.
3.
Tanaka, Mizuki, Yu Yoshida, Shiori Hasegawa, et al.. (2024). Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database. BMC Complementary Medicine and Therapies. 24(1). 121–121. 6 indexed citations
4.
5.
Nakao, Satoshi, et al.. (2023). Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal income. Journal of Pharmaceutical Policy and Practice. 16(1). 27–27. 4 indexed citations
6.
Nakao, Satoshi, Nanaka Ichihara, Hideyuki Tanaka, et al.. (2023). Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. 9(11). e21891–e21891. 3 indexed citations
7.
Suetsugu, Kimitaka, Kojiro Hata, Satoshi Nakao, et al.. (2023). Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes. International Journal of Clinical Oncology. 28(7). 860–871. 13 indexed citations
8.
Iwamoto, Hiroshi, Shintaro Miyamoto, Satoshi Nakao, et al.. (2022). Association Between Patient Preference for Inhaler Medications and Asthma Outcomes. Journal of Asthma and Allergy. Volume 15. 1539–1547. 2 indexed citations
9.
Yamaguchi, Kakuhiro, Koji Kurose, Satoshi Nakao, et al.. (2022). Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology. 28(4). 380–388. 1 indexed citations
10.
Nakao, Satoshi, Shiori Hasegawa, Ryogo Umetsu, et al.. (2021). Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database. BMC Pharmacology and Toxicology. 22(1). 8 indexed citations
11.
Yamaguchi, Kakuhiro, Satoshi Nakao, Hiroshi Iwamoto, et al.. (2021). Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients. Scientific Reports. 11(1). 10105–10105. 7 indexed citations
12.
Hasegawa, Shiori, Hiroaki Ikesue, Satoshi Nakao, et al.. (2020). Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database. Pharmacoepidemiology and Drug Safety. 29(10). 1279–1294. 27 indexed citations
13.
Nakao, Satoshi, Shiori Hasegawa, Mizuki Tanaka, et al.. (2020). Evaluation of anti-infective-related Clostridium difficile-associated colitis using the Japanese Adverse Drug Event Report database. International Journal of Medical Sciences. 17(7). 921–930. 7 indexed citations
14.
Motooka, Yumi, Sayaka Sasaoka, Haruna Hatahira, et al.. (2018). Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database. SAGE Open Medicine. 6. 2105844475–2105844475. 11 indexed citations
15.
Sasaoka, Sayaka, Haruna Hatahira, Shiori Hasegawa, et al.. (2017). Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database. YAKUGAKU ZASSHI. 138(1). 123–134. 7 indexed citations
16.
Mazzolini, Piero, Valeria Russo, Carlo S. Casari, et al.. (2016). Vibrational–Electrical Properties Relationship in Donor-Doped TiO2 by Raman Spectroscopy. The Journal of Physical Chemistry C. 120(33). 18878–18886. 49 indexed citations
17.
Hirose, Yasushi, et al.. (2013). Full compensation of oxygen vacancies in EuTiO3 (001) epitaxial thin film stabilized by a SrTiO3 surface protection layer. Applied Physics Letters. 102(4). 18 indexed citations
18.
Hitosugi, Taro, Miki Moriyama, Ngoc Lam Huong Hoang, et al.. (2010). Properties of TiO2-based transparent conducting oxide thin films on GaN(0001) surfaces. Journal of Applied Physics. 107(5). 40 indexed citations
19.
Yamaguchi, Takeo, Fusae Miyata, & Satoshi Nakao. (2003). Polymer Electrolyte Membranes with a Pore‐Filling Structure for a Direct Methanol Fuel Cell. Advanced Materials. 15(14). 1198–1201. 111 indexed citations
20.
Chu, Liang‐Yin, Takeo Yamaguchi, & Satoshi Nakao. (2002). A Molecular-Recognition Microcapsule for Environmental Stimuli-Responsive Controlled Release. Advanced Materials. 14(5). 386–386. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei‐Rong Huang Breakdown of academic impact, for papers by Xianliang Li Breakdown of academic impact, for papers by Shoji Nagaoka Breakdown of academic impact, for papers by Xiaoli Liu Breakdown of academic impact, for papers by Peng Li Breakdown of academic impact, for papers by Guisheng Qi Breakdown of academic impact, for papers by Lili Jiang Breakdown of academic impact, for papers by Jihui Li Breakdown of academic impact, for papers by Xiaoqing Wang Breakdown of academic impact, for papers by D. Lerche
Rankless by CCL
2026